Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Yap

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
BMC Medical Research Methodology|July 4, 2013
Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemiaChristina Yap, Andrew Pettitt, Lucinda Billingham
Contemporary Clinical Trials|July 1, 2023
Reporting quality of CONSORT flow diagrams in published early phase dose-finding clinical trial reports: Improvement is neededEmily Alger, Yuqi Zhang, Christina Yap
Harvard Data Science Review|November 27, 2023
Personalized (N-of-1) Trials for Patient-Centered Treatments of MultimorbidityJerry M Suls, Catherine Alfano, Christina Yap
Drug Discovery Today|February 2, 2020
From patent to patient: analysing access to innovative cancer drugsEva Sharpe, Richard Hoey, Christina Yap, et al.
BMC Medicine|August 3, 2019
When to keep it simple - adaptive designs are not always usefulJames M S Wason, Peter Brocklehurst, Christina Yap
Statistical Methods in Medical Research|April 30, 2026
PRO-ADD: Patient-empowered dose-finding trials integrating safety, preliminary efficacy and patient-reported outcomes for optimal dose selectionEmily Alger, Sumithra J Mandrekar, Jun Yin, et al.
Frontiers in Oncology|January 23, 2015
Challenges of clinical trial design for targeted agents against pediatric leukemiasFrancis Jay Mussai, Christina Yap, Christopher Mitchell, et al.
Cancer Medicine|October 22, 2021
Trends in patient-reported outcome use in early phase dose-finding oncology trials - an analysis of ClinicalTrials.govJulia Lai-Kwon, Zhulin Yin, Anna Minchom, et al.
Statistical Methods in Medical Research|June 18, 2025
Response adaptive randomisation in clinical trials: Current practice, gaps and future directionsIsabelle Wilson, Steven Julious, Christina Yap, et al.
Contemporary Clinical Trials|November 18, 2021
Implementation of platform trials in the COVID-19 pandemic: A rapid reviewAlyssa M Vanderbeek, Judith M Bliss, Zhulin Yin, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
BMC Medical Research Methodology|July 4, 2013
Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemiaChristina Yap, Andrew Pettitt, Lucinda Billingham
Contemporary Clinical Trials|July 1, 2023
Reporting quality of CONSORT flow diagrams in published early phase dose-finding clinical trial reports: Improvement is neededEmily Alger, Yuqi Zhang, Christina Yap
Harvard Data Science Review|November 27, 2023
Personalized (N-of-1) Trials for Patient-Centered Treatments of MultimorbidityJerry M Suls, Catherine Alfano, Christina Yap
Drug Discovery Today|February 2, 2020
From patent to patient: analysing access to innovative cancer drugsEva Sharpe, Richard Hoey, Christina Yap, et al.
BMC Medicine|August 3, 2019
When to keep it simple - adaptive designs are not always usefulJames M S Wason, Peter Brocklehurst, Christina Yap
Statistical Methods in Medical Research|April 30, 2026
PRO-ADD: Patient-empowered dose-finding trials integrating safety, preliminary efficacy and patient-reported outcomes for optimal dose selectionEmily Alger, Sumithra J Mandrekar, Jun Yin, et al.
Frontiers in Oncology|January 23, 2015
Challenges of clinical trial design for targeted agents against pediatric leukemiasFrancis Jay Mussai, Christina Yap, Christopher Mitchell, et al.
Cancer Medicine|October 22, 2021
Trends in patient-reported outcome use in early phase dose-finding oncology trials - an analysis of ClinicalTrials.govJulia Lai-Kwon, Zhulin Yin, Anna Minchom, et al.
Statistical Methods in Medical Research|June 18, 2025
Response adaptive randomisation in clinical trials: Current practice, gaps and future directionsIsabelle Wilson, Steven Julious, Christina Yap, et al.
Contemporary Clinical Trials|November 18, 2021
Implementation of platform trials in the COVID-19 pandemic: A rapid reviewAlyssa M Vanderbeek, Judith M Bliss, Zhulin Yin, et al.
Pageof 9